International Scholarly Research Notices / 2013 / Article / Tab 1

Research Article

Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients

Table 1

Socio-demographic characteristics of study population ( ).

VariablesType of Statin
Atorvastatin 
( ) 
(%)
Rosuvastatin 
( )  
(%)
Pravastatin 
( )  
(%)

Age (Mean ± SD)
Age group
 <65 years117 (78.0)80 (80.0)76 (76.0)
 ≥65 years33 (22.0)20 (20.0)24 (24.0)

Nationality
 Qatari110 (73.3)69 (69.0)79 (79.0)
 Non-Qatari40 (26.7)31 (31.0)21 (21.0)
Gender
 Male54 (36.0)55 (55.0)34 (34.0)
 Female96 (64.0)45 (45.0)66 (66.0)

BMI (Mean ± SD)

BMI group
 <25 kg/m210 (6.7)11 (11.0)8 (8.0)
 25–30 kg/m240 (26.7)36 (36.0)23 (23.0)
 ≥30 kg/m2100 (66.7)53 (53.0)69 (69.0)

Smokers
 Yes19 (12.7)17 (17.0)12 (12.0)
 No131 (87.3)83 (83.0)88 (88.0)

Alcohol consumer
 Yes2 (1.3)1 (1.0)5 (5.0)
 No148 (98.7)99 (99.0)95 (95.0)

HTN
 Yes130 (86.7)95 (95.0)94 (94.0)
 No20 (13.3)5 (5.0)6 (6.0)

DM
 Type I6 (4.0)7 (7.0)
 Type II144 (96.0)93 (93.0)100 (100)

DM duration
 <5 years17 (11.3)18 (18.0)9 (9.0)
 5–10 years47 (31.3)35 (35.0)35 (35.0)
 >10 years86 (57.3)47 (47.0)56 (56.0)

Continuous variables are presented as mean ± SD and categorical variables as numbers (percentages).